Szalay G, Hess J, Kaufmann S H
Department of Immunology, University of Ulm, Germany.
Infect Immun. 1995 Aug;63(8):3187-95. doi: 10.1128/iai.63.8.3187-3195.1995.
The intracellular pathogen Listeria monocytogenes replicates mainly in resting macrophages and hepatocytes residing in infected tissues. Both innate and acquired resistance strongly depend on activation of listericidal capacities of macrophages by gamma interferon (IFN-gamma) produced by natural killer cells and T lymphocytes. In contrast to macrophages, hepatocytes have been considered to serve purely as a cellular habitat, prolonging survival of the pathogen in the host. By using an immortalized murine hepatocyte line, the relationship between L. monocytogenes and this cell type has been analyzed in more detail. Our data reveal that hepatocytes are able to eradicate listeriolysin-deficient (avirulent) L. monocytogenes but fail to control growth of listeriolysin-expressing (virulent) L. monocytogenes organisms. Following stimulation with IFN-gamma, hepatocytes gained the capacity to restrict growth of virulent L. monocytogenes, although less efficiently than the highly listericidal IFN-gamma-activated macrophages. Hepatocytes costimulated with a combination of IFN-gamma, interleukin 6 (IL-6), and tumor necrosis factor alpha (TNF-alpha) expressed the highest antilisterial activities. Although IFN-gamma-stimulated hepatocytes produced demonstrable levels of reactive nitrogen intermediates (RNI), the results of inhibition studies do not support a major role for these molecules in antilisterial hepatocyte activities. In contrast, inhibition of RNI produced by macrophages neutralized their antilisterial effects. IFN-gamma-stimulated, L. monocytogenes-infected hepatocytes expressed TNF-alpha mRNA, suggesting that they are a source of this cytokine during listeriosis. These studies suggest a novel function for hepatocytes in listeriosis: first, IFN-gamma-stimulated hepatocytes could contribute to listerial growth restriction in the liver, and second, through secretion of proinflammatory cytokines, they could promote phagocyte influx to the site of listerial growth.
细胞内病原体单核细胞增生李斯特菌主要在感染组织中的静息巨噬细胞和肝细胞内复制。先天性和获得性抗性都强烈依赖于自然杀伤细胞和T淋巴细胞产生的γ干扰素(IFN-γ)激活巨噬细胞的杀李斯特菌能力。与巨噬细胞不同,肝细胞一直被认为纯粹是一种细胞栖息地,延长了病原体在宿主体内的存活时间。通过使用永生化小鼠肝细胞系,对单核细胞增生李斯特菌与这种细胞类型之间的关系进行了更详细的分析。我们的数据显示,肝细胞能够清除缺乏李斯特菌溶素(无毒)的单核细胞增生李斯特菌,但无法控制表达李斯特菌溶素(有毒)的单核细胞增生李斯特菌的生长。在用IFN-γ刺激后,肝细胞获得了限制有毒单核细胞增生李斯特菌生长的能力,尽管效率低于高度杀李斯特菌的IFN-γ激活的巨噬细胞。用IFN-γ、白细胞介素6(IL-6)和肿瘤坏死因子α(TNF-α)联合刺激的肝细胞表现出最高的抗李斯特菌活性。尽管IFN-γ刺激的肝细胞产生了可检测水平的活性氮中间体(RNI),但抑制研究结果不支持这些分子在肝细胞抗李斯特菌活性中起主要作用。相比之下,抑制巨噬细胞产生的RNI可中和其抗李斯特菌作用。IFN-γ刺激的、感染单核细胞增生李斯特菌的肝细胞表达TNF-α mRNA,表明它们是李斯特菌病期间这种细胞因子的来源。这些研究表明肝细胞在李斯特菌病中有一个新功能:第一,IFN-γ刺激的肝细胞可能有助于限制肝脏中李斯特菌的生长;第二,通过分泌促炎细胞因子,它们可以促进吞噬细胞流入李斯特菌生长部位。